Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2-Reference-Cited by-同舟云学术

Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2

Published:2023-03-14 Issue:4 Volume:14 Page:432-441
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Davis-Gilbert Zachary W.¹,Krämer Andreas²³⁴,Dunford James E.⁵^ORCID,Howell Stefanie¹,Senbabaoglu Filiz⁵,Wells Carrow I.¹^ORCID,Bashore Frances M.¹^ORCID,Havener Tammy M.¹^ORCID,Smith Jeffery L.¹,Hossain Mohammad A.¹^ORCID,Oppermann Udo⁵⁶,Drewry David H.¹⁷^ORCID,Axtman Alison D.¹^ORCID

Affiliation:

1. Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

2. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Strabe 9, Frankfurt 60438, Germany

3. Structural Genomics Consortium, Buchmann Institute for Life Sciences, Goethe University Frankfurt, Max-von-Laue-Strabe 15, Frankfurt 60438, Germany

4. Frankfurt Cancer Institute, Paul-Ehrlich-Straße 42-44, Frankfurt 60596, Germany

5. Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7LD, United Kingdom

6. Oxford Translational Myeloma Centre, University of Oxford, Oxford OX3 7LD, United Kingdom

7. UNC Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

Canada Foundation for Innovation

Funda??o Amaz?nia Paraense de Amparo ? Pesquisa

Innovative Medicines Initiative

Genome Canada

Ontario Genomics Institute

North Carolina Biotechnology Center

U.S. Department of Defense

National Institutes of Health

Eshelman Institute for Innovation, University of North Carolina

Cancer Research UK

Fondation Leducq